ReviewInternational journal of molecular sciences2022

Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes.

Hussein Awada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.